title: Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior.
abstract: A large body of evidence suggests a potential role for catecholaminergic function as a possible biological factor in the control of suicidal behavior. Recently, we have used a neuroendocrine strategy to study dopaminergic and noradrenergic activities in depressed suicide attempters. However, some problems are associated with the use of growth hormone (GH) response to catecholaminergic challenge, because GH release could be decreased by a direct effect of corticosteroids at the pituitary level. Therefore, the purpose of the present study was to assess GH response to both apomorphine, a dopaminergic agonist, and clonidine, an alpha2-adrenergic agonist, according to the dexamethasone suppression test (DST) status in a sample of 20 major depressed inpatients with a history of suicide attempt compared with nonattempters. Our results tended to show that hypercortisolemia as assessed by post-DST cortisol values did not inhibit GH response to apomorphine or clonidine, suggesting that hypothalamo-pituitary-adrenal axis overactivity does not explain the impaired GH response to apomorphine in major depressed patients with a history of suicide attempt.
authors.affiliation: Psychiatric Unit, CHU Sart Tilman, Liège, Belgium. wpitchot@chu.ulg.ac.be
authors.forename: William
authors.initials: W
authors.lastname: Pitchot
authors.forename: Jean
authors.initials: J
authors.lastname: Reggers
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Pinto
authors.forename: Michel
authors.initials: M
authors.lastname: Hansenne
authors.forename: Marc
authors.initials: M
authors.lastname: Ansseau
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000328:Adult; D001058:Apomorphine / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism*; D003000:Clonidine / Q000494:pharmacology; D003865:Major Depressive Disorder / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology; D003907:Dexamethasone / Q000494:pharmacology; D018491:Dopamine Agonists / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D008297:Male; D010913:Pituitary-Adrenal System / Q000503:physiopathology*; D013406:Suicide, Attempted / Q000523:psychology / Q000706:statistics & numerical data*
chemical_list: D000316:Adrenergic alpha-Agonists; D002395:Catecholamines; D018491:Dopamine Agonists; D005938:Glucocorticoids; D003907:Dexamethasone; D013006:Growth Hormone; D003000:Clonidine; D001058:Apomorphine